Back to Journals » International Journal of Nanomedicine » Volume 7

Detection of micrometastases in lung cancer with magnetic nanoparticles and quantum dots

Authors Wang Y, Zhang Y, Du, Wu, Zhang G

Received 6 February 2012

Accepted for publication 17 March 2012

Published 7 May 2012 Volume 2012:7 Pages 2315—2324

DOI https://doi.org/10.2147/IJN.S30593

Review by Single-blind

Peer reviewer comments 3


Yali Wang, Yucheng Zhang*, Zhenwu Du, Mei Wu, Guizhen Zhang*

Central Laboratory, China-Japan Union Hospital, Jilin University, Changchun, People’s Republic of China

*These authors contributed equally to this work

Abstract: Detection of micrometastases plays an important role in early-stage and recurrent cancer diagnosis. In the study, a new method of screening micrometastases of lung cancer in peripheral blood by magnetic nanoparticles (MNPs) and quantum dots (QDs) was developed to achieve early diagnosis and recurrence prevention. MNPs were prepared by combining miniemulsion polymerization and Stöber coating methods. QDs were prepared by using Cd(Ac)2 • 2H2O and oxygen-free NaHTe with thioglycolic acid as the stabilizer. The carbodiimide-mediated condensation method was used to couple pan-cytokeratin (pan-ck) antibody (Ab) to the surface of the MNPs, and Lunx and SP-A Abs to the surface of the QDs. After four kinds of epithelial tumor cells were enriched by MNPs coupled with pan-ck Ab (MNP-pan-ck), lung cancer cells A549 and SPC-A-1 were successfully identified by QDs with double-labeled Abs. Finally, 32 patients with non-small cell lung cancer (NSCLC) were collected, out of 26 cases with the enriched circulating tumor cells (CTCs), 21 cases were successfully identified by QDs. Therefore, a new method was established in which MNP-pan-ck collected CTCs and QDs with double-labeled Abs could be used simultaneously to identify CTCs from NSCLC patients.

Keywords: micrometastases, lung cancer, magnetic nanoparticles, quantum dots, Lunx, SP-A

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]